Related Experiment Video
Updated: Jan 30, 2026

In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
Published on: September 25, 2021
Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A
Zhongzhi Tang1, Ying Tang, Libo Fu
1Wuhan General Hospital, Guangzhou Command of PLA, Wuhan 430070.
Abstract:
In order to study the effect of tanshinone II A on growth and apoptosis in human hepatoma cell line BEL-7402 in vitro, the human hepatoma cell line BEL-7402 was treated with tanshinone II A at various concentrations for 72 h. Growth suppression was evaluated by MTT assay; apoptosis-related alterations in morphology and biochemistry were ascertained under cytochemical staining (Hoechst 33258), transmission electron microscopy (TEM), and DNA agarose gel electrophoresis. Apoptotic rate was quantified by flow cytometry (FCM). The results showed that Tanshinone II A could inhibit the growth of hepatoma cells in a dose-dependent manner, with IC50 value being 6.28 micrograms/ml. After treatment with 1-10 micrograms/ml tanshinone II A for 72 h, BEL-7402 cells apoptosis with nuclear chromatin condensation and fragmentation as well as cell shrinkage and the formation of apoptotic bodies were observed. DNA ladder could be demonstrated on DNA electrophoresis. FCM analysis showed hypodiploid peaks on histogram, and the apoptotic rates at 5 micrograms/ml concentration for 12 h, 24 h, 36 h, 48 h and 72 h were (2.32 +/- 0.16)%, (3.01 +/- 0.35)%, (3.87 +/- 0.43)%, (6.73 +/- 0.58)% and (20.85 +/- 1.74)% respectively, which were all significantly higher than those in the control group (1.07 +/- 0.13)%. It is concluded that Tanshinone II A could induce human hepatoma cell line BEL-7402 apoptosis, which may be related to the mechanism of growth inhibition.
Insights
Tanshinone II A effectively inhibits human hepatoma BEL-7402 cell growth and induces apoptosis in a dose-dependent manner. This compound demonstrates potential as a therapeutic agent for liver cancer by triggering programmed cell death.
Area of Science:
- Hepatology
- Molecular Biology
- Pharmacology
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Identifying novel therapeutic agents for HCC is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the in vitro effects of tanshinone II A on the growth and apoptosis of the human hepatoma cell line BEL-7402.
- To elucidate the potential mechanisms underlying tanshinone II A-induced cell death.
Main Methods:
- Human hepatoma BEL-7402 cells were treated with varying concentrations of tanshinone II A.
- Cell viability was assessed using MTT assay.
- Apoptosis was evaluated through Hoechst 33258 staining, transmission electron microscopy (TEM), DNA agarose gel electrophoresis, and flow cytometry (FCM).
Main Results:
- Tanshinone II A exhibited dose-dependent growth inhibition of BEL-7402 cells, with an IC50 of 6.28 µg/ml.
- Morphological and biochemical hallmarks of apoptosis, including chromatin condensation, cell shrinkage, and DNA fragmentation (DNA ladder), were observed.
- FCM analysis revealed a significant increase in hypodiploid peaks, indicating apoptosis induction, with rates reaching 20.85% after 72 hours of exposure to 5 µg/ml tanshinone II A.
Conclusions:
- Tanshinone II A effectively induces apoptosis in human hepatoma BEL-7402 cells in vitro.
- The induction of apoptosis by tanshinone II A is a key mechanism contributing to its observed growth-inhibitory effects on hepatoma cells.
Related Concept Videos
Enzyme Inhibition
Apoptosis
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Primary and Secondary Growth in Roots and Shoots
Induction
A...

